478 related articles for article (PubMed ID: 10454584)
1. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.
Vigo E; Müller H; Prosperini E; Hateboer G; Cartwright P; Moroni MC; Helin K
Mol Cell Biol; 1999 Sep; 19(9):6379-95. PubMed ID: 10454584
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
Santoni-Rugiu E; Falck J; Mailand N; Bartek J; Lukas J
Mol Cell Biol; 2000 May; 20(10):3497-509. PubMed ID: 10779339
[TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
Lukas J; Petersen BO; Holm K; Bartek J; Helin K
Mol Cell Biol; 1996 Mar; 16(3):1047-57. PubMed ID: 8622649
[TBL] [Abstract][Full Text] [Related]
4. Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression.
Chen X; Prywes R
Mol Cell Biol; 1999 Jul; 19(7):4695-702. PubMed ID: 10373518
[TBL] [Abstract][Full Text] [Related]
5. E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest.
Iavarone A; Massagué J
Mol Cell Biol; 1999 Jan; 19(1):916-22. PubMed ID: 9858615
[TBL] [Abstract][Full Text] [Related]
6. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.
Katich SC; Zerfass-Thome K; Hoffmann I
Oncogene; 2001 Feb; 20(5):543-50. PubMed ID: 11313986
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein.
Buchmann AM; Swaminathan S; Thimmapaya B
Mol Cell Biol; 1998 Aug; 18(8):4565-76. PubMed ID: 9671466
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
11. E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.
Wu L; Goodwin EC; Naeger LK; Vigo E; Galaktionov K; Helin K; DiMaio D
Mol Cell Biol; 2000 Oct; 20(19):7059-67. PubMed ID: 10982822
[TBL] [Abstract][Full Text] [Related]
12. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.
Müller H; Moroni MC; Vigo E; Petersen BO; Bartek J; Helin K
Mol Cell Biol; 1997 Sep; 17(9):5508-20. PubMed ID: 9271426
[TBL] [Abstract][Full Text] [Related]
13. cdc25A is necessary but not sufficient for optimal c-myc-induced apoptosis and cell proliferation of vascular smooth muscle cells.
Macdonald K; Bennett MR
Circ Res; 1999 Apr; 84(7):820-30. PubMed ID: 10205150
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas J; Herzinger T; Hansen K; Moroni MC; Resnitzky D; Helin K; Reed SI; Bartek J
Genes Dev; 1997 Jun; 11(11):1479-92. PubMed ID: 9192874
[TBL] [Abstract][Full Text] [Related]
16. The retinoblastoma protein binds to a family of E2F transcription factors.
Lees JA; Saito M; Vidal M; Valentine M; Look T; Harlow E; Dyson N; Helin K
Mol Cell Biol; 1993 Dec; 13(12):7813-25. PubMed ID: 8246996
[TBL] [Abstract][Full Text] [Related]
17. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.
Müller H; Bracken AP; Vernell R; Moroni MC; Christians F; Grassilli E; Prosperini E; Vigo E; Oliner JD; Helin K
Genes Dev; 2001 Feb; 15(3):267-85. PubMed ID: 11159908
[TBL] [Abstract][Full Text] [Related]
18. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
[TBL] [Abstract][Full Text] [Related]
19. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
20. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
